RUN EFFICIENT 

CLINICAL TRIALS

Althian offers a one stop solution for conducting clinical trials in Mexico. We can run your clinical trials faster, better and at a lower cost.
We conduct Phase I, Phase II, Phase III and Phase IV studies. We are also able to perform studies of bioavailablity and bioequivalence in our partner's fully certified laboratory. Our own commercial IRB speeds up the regulatory process. We have a great team of highly skilled, experienced and enthusiastic Investigators.

 

Althian Clinical Research Mexico

New research in type 1 diabetes using PD-L1

Type 1 diabetes is an autoinmune condition in which the immune cells attack the islet cells in the pancreas that...

Zydus Cadila’s LipaglynTM (Saroglitazar Magnesium) receives regulatory approval in Mexico

Zydus Cadila is an innovative, global pharmaceutical company who is eager to create healthier communities all around the world. In...

Alternative options for renal cell carcinoma

The renal cell carcinoma (RCC) is the eight most common and aggressive cancer.  Unfortunately, there are poor treatments methods. Right...

Insights in non-alcoholic steatohepatitis (NASH)

Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD) which occurs when fat builds up on the...

What’s new in multiple sclerosis treatment research?

Multiple sclerosis (MS) is an inflammatory, neurodegenerative disease that affects the central nervous system by making it a potentially disabling...

New proposals for oncology treatment: nanomedicine

In recent years, novel therapies for cancer have been proposed. Nanomedicine is the new field that has a novel proposal:...

Eli Lilly’s Verzenio™ (Abemaciclib) receives FDA approval for certain advanced breast cancers

Last week the Food and Drug Administration (FDA) announced the approval of Eli Lilly’s breast cancer drug: Verzenio™ (Abemaciclib). This...

Althian: a top 5 best recruiter worldwide

Althian Clinical Research is currently participating in a phase IIb clinical trial for Guerbet Pharmaceuticals. This study has been challenging...

The biosimilars era

In recent years, the development of new drugs that are more specific to a determined condition has led to an...

FDA approves the first biosimilar treatment for cancer

On September 14th 2017, the FDA announced the first approval for a biosimilar drug to treat cancer. This is the...

Visit Us On FacebookVisit Us On Linkedin